Farid and Ah Fong graduated from a university in 2020 with a qualification in Bachelor of Business and Commerce. They decided to form a business offering advice to clients who wish to grow their businesses on a large scale. Fatimah who is a novice businesswoman is looking for a successful business partner in order to grow her business. She met a businessman by the name Felix but she is unsure of his financial credibility. She approached Farid and Ah Fong for consultation and advice as she came across their advertisement in the social media. Farid and Ah Fong did thorough business research and recommended to Fatimah to proceed to have a business dealing with Felix as a business partner. Fatimah approached Felix and entered into a multi-million-dollar project. After a few months, Fatimah discovered that Felix is a financially troubled businessman. Fatimah is very upset. She approached Farid and Ah Fong for a clarification. However, Farid and Ah Fong claimed that they have conducted thorough research on Felix’s financial standing. However, it has now transpired that Farid and Ah Fong did not look at the financial standing of Felix for the year 2018 but only looked at the financial standing for the year 2019. They claimed that there is no need to check the financial standing for the last two years. They also claimed that since they just graduated, they do not have much experience. Fatimah seeks your advice as to her rights against Farid and Ah Fong

4. A) The probability that a student from a certain university has a cell phone is 0.2. So, the probability that the tenth student randomly interviewed at this university is the fifth with Cell phones is:

B) On a certain day, the second stage of the environmental contingency plan was implemented in the Mexico City. If there are 50 companies in the area that corresponds to a supervisor, of which 15 did not follow contingency guidelines, then the probability that 3 companies out of the 10 that are verified will not follow the guidelines is:

C)If the planes arriving at an airport follow a Poisson process with an average rate of 8 planes per hour. The probability of exactly 10 aircraft arriving in the next 2 hours is as close to:

Assume the role of a University instructor that is attempting to communicate concepts from the required reading. In 200 words or more, discuss the Weighted Average Method and First In First Out Method, and describe these concepts using examples to illustrate your points.

What is meant by the term culture? In what way can measuring attitudes about the following help to differentiate between cultures: centralized and decentralized decision making, safety and risk, individual or group rewards, high or low organizational loyalty, cooperation or competition? Use these attitudes to compare the US, Germany, and Japan. Based on your comparisons, what conclusions can you draw regarding the impact of culture on motivation, leadership and human resource management of MNCs? Use REFERENCES do back up your answer.

1. Provide a high-level overview of the US health care system. Discuss how your personal worldview may influence your perspective on the healthcare system in relation to cost, quality, and access.(include references)

2. Discuss the commonalities and differences between individual and population health. Provide an example of each, along with a time when a provider would be concerned about both concurrently.(include references)

3. The Pareto efficiency is a simple idea, but it is difficult to achieve. Why is this? Provide an example (include references)

Case Study 1
Quick Biotech
It is late in September 2010, and Michelle Chang, a doctoral student at the National
University of Singapore (NUS), is to meet her colleagues Henry Tan and Mike
Hammer from the Institute of Molecular Biology again in a few days to discuss the
course of action to be pursued for the establishment of Quick Biotech. Henry Tan
and Mike Hammer both hold doctorates in biology and work at NUS as senior
assistants. A few months before, they patented a process for the production of multi
protein complexes, which they had already put to successful use, and about which
they had received favourable feedback. Now, the three colleagues want to set-up a
company called Quick Biotech in order to apply the new technology to a wider field.
Background
The human body is exposed to numerous external influences and internal genetic
defects, which cause the proteins in our cells to malfunction. Proteins constitute the
basis of all biological processes. If proteins no longer fulfill their function adequately
owing to defects, this often results in life-threatening illnesses, such as cancer. This
is why almost all drugs have effect on proteins. Consequently, most research and
development work for drugs and therapies need protein, which is why both academic
research institutions and the pharmaceutical companies use proteins as a basis to
their research activities.
Recently, progress in fundamental research revealed the total of the proteins in a
cell, which in the case of human being amounts to more than 40,000 proteins. It
became obvious that the proteins in a cell do not work individually; rather, they
combine to act as protein complexes that are made up of numerous protein
components. In addition, virtually all biological processes in cells are executed by
such protein complexes. This has crucial consequences for research; in order to
understand how proteins work, protein machines must be explored as a whole, and
not only their individual protein components.
Nonetheless, academic institutes and the pharmaceutical industry have almost
exclusively focused on individual, isolated proteins. The primary reason for this was
that human protein machines are very difficult to produce in a pure form. Although
the development of modern, recombinant methods now enables the production of
individual protein components, there is still a demand for a technology that is able to
provide sufficient volumes of entire protein machine, which form the basis of
biological functions. This is also Michelle’s, Henry’s and Mike’s experience in their
research at NUS. They realize that no suitable technology for the production of
protein machines exists. This is why they developed their own technology: the
MultiBac technology.
The technology
The MultiBac technology uses a modified, yet greatly improved version of the so
called “baculovirus gene transfer vector” to produce any combination of proteins in
great volumes and of high quality. The genes of a great number of proteins, such as
human ones, can be placed on this gene transfer vector. This process can be carried
out in an ordinary molecular biology laboratory. The MultiBca gene transfer vector
multiplies in cell cultures and constitutes no danger to human beings. Therefore, no
special health and safety regulations are required to work with this system.
The gene transfer vector of the MultiBac system was developed to provide it with a
unique feature namely, that is particularly careful in the production of the desired
protein machines. For customers, this is a guarantee of the unsurpassed quality of
the protein complex produced with the MultiBac technology. In comparison with
conventional processes, the simplified MultiBac technology additionally saves a
substantial amount of time for the production of the desired protein product: it only
takes weeks rather than months. Also, the technology offers the possibility to build
numerous different protein complexes from the same protein components on a
modular basis and, thus, of supplying individual solution to customers’ problems.
Laboratories of renowned research institutes already use MultiBac, which NUS has
made available as trial specimens. This shows that the technology works, is mature
and has a selling potential. The process was patented last year by NUS, and since
then it was developed in the context of employment at the university. However, the
rights can be assigned to a start up, for instance, in the form of an exclusive license.
The next steps to launch the venture
In autumn 2010, Michelle is in the final stages of her doctoral thesis, which she
wants to complete by the year. After that, she needs to work full time for the new
company. In contrast, Henry and Mike want to retain their jobs at NUS and spend
less time on the company. As such, they would not be involved in the company’s
operative daily business but will assume an advisory function. They will receive
shares in the start-up but will not be on the company payroll.
One of the key roles of Henry and Mike will be to guarantee long term access to the
latest findings in scientific research. This model, whereby some of the founders
remain at the university, has already proved successful in a number of other
biotechnology start ups. Research in the field of biotechnology is very costly; both in
terms of time and money, so only by retaining close links with a research institution
will the company ensure that it will always work with the latest technologies and,
thus, remain competitive.
One of the greatest challenges currently perceived by the team is to secure funding
for the new company. Although the founders are able to invest S$200, 000 of their
personal savings into the enterprise and, thus, realize a small scale start up, present
plans are based on the assumption that at least S$500 000 of external capital will be
needed for the first two years.
These funds will primarily serve to finance Michelle’s position and a small team of lab
assistants in charge of producing the protein complex for the clients. The product will
be sold via a network of sales agents, and other functions, such as accounting and
finance, will be outsourced to a professional accountant.
Answer all questions.
1. Should Michelle consider debt or equity to finance QuickBiotech? Explain your
answer.

2. Would you consider any alternative sources or finance? Which one? Why?

3. Analyse other issues to be addressed before QuickBiotech is launched.

Please write all your answers in essay format. Do not answer in point-form unless
the questions mention “List” or “State”. It is not necessary to precede each answer
with an introduction and end with a summary. Proceed directly with the answer

Case Study 1
Quick Biotech
It is late in September 2010, and Michelle Chang, a doctoral student at the National
University of Singapore (NUS), is to meet her colleagues Henry Tan and Mike Hammer from the Institute of Molecular Biology again in a few days to discuss the course of action to be pursued for the establishment of Quick Biotech. Henry Tan and Mike Hammer both hold doctorates in biology and work at NUS as senior assistants. A few months before, they patented a process for the production of multi protein complexes, which they had already put to successful use, and about which they had received favourable feedback. Now, the three colleagues want to set-up a company called Quick Biotech in order to apply the new technology to a wider field.

Background
The human body is exposed to numerous external influences and internal genetic defects, which cause the proteins in our cells to malfunction. Proteins constitute the basis of all biological processes. If proteins no longer fulfill their function adequately owing to defects, this often results in life-threatening illnesses, such as cancer. This is why almost all drugs have effect on proteins. Consequently, most research and development work for drugs and therapies need protein, which is why both academic research institutions and the pharmaceutical companies use proteins as a basis to their research activities.

Recently, progress in fundamental research revealed the total of the proteins in a cell, which in the case of human being amounts to more than 40,000 proteins. It became obvious that the proteins in a cell do not work individually; rather, they combine to act as protein complexes that are made up of numerous protein components. In addition, virtually all biological processes in cells are executed by such protein complexes. This has crucial consequences for research; in order to understand how proteins work, protein machines must be explored as a whole, and not only their individual protein components.

Nonetheless, academic institutes and the pharmaceutical industry have almost exclusively focused on individual, isolated proteins. The primary reason for this was that human protein machines are very difficult to produce in a pure form. Although the development of modern, recombinant methods now enables the production of individual protein components, there is still a demand for a technology that is able to provide sufficient volumes of entire protein machine, which form the basis of biological functions. This is also Michelle’s, Henry’s and Mike’s experience in their research at NUS. They realize that no suitable technology for the production of protein machines exists. This is why they developed their own technology: the MultiBac technology.

The technology
The MultiBac technology uses a modified, yet greatly improved version of the so called “baculovirus gene transfer vector” to produce any combination of proteins in great volumes and of high quality. The genes of a great number of proteins, such as human ones, can be placed on this gene transfer vector. This process can be carried out in an ordinary molecular biology laboratory. The MultiBca gene transfer vector multiplies in cell cultures and constitutes no danger to human beings. Therefore, no special health and safety regulations are required to work with this system.

The gene transfer vector of the MultiBac system was developed to provide it with a unique feature namely, that is particularly careful in the production of the desired protein machines. For customers, this is a guarantee of the unsurpassed quality of the protein complex produced with the MultiBac technology. In comparison with conventional processes, the simplified MultiBac technology additionally saves a substantial amount of time for the production of the desired protein product: it only takes weeks rather than months. Also, the technology offers the possibility to build numerous different protein complexes from the same protein components on a modular basis and, thus, of supplying individual solution to customers’ problems.

Laboratories of renowned research institutes already use MultiBac, which NUS has made available as trial specimens. This shows that the technology works, is mature and has a selling potential. The process was patented last year by NUS, and since then it was developed in the context of employment at the university. However, the rights can be assigned to a start up, for instance, in the form of an exclusive license.

The next steps to launch the venture
In autumn 2010, Michelle is in the final stages of her doctoral thesis, which she wants to complete by the year. After that, she needs to work full time for the new company. In contrast, Henry and Mike want to retain their jobs at NUS and spend less time on the company. As such, they would not be involved in the company’s operative daily business but will assume an advisory function. They will receive shares in the start-up but will not be on the company payroll.
One of the key roles of Henry and Mike will be to guarantee long term access to the latest findings in scientific research. This model, whereby some of the founders remain at the university, has already proved successful in a number of other biotechnology start ups. Research in the field of biotechnology is very costly; both in terms of time and money, so only by retaining close links with a research institution will the company ensure that it will always work with the latest technologies and, thus, remain competitive.

One of the greatest challenges currently perceived by the team is to secure funding for the new company. Although the founders are able to invest S$200, 000 of their personal savings into the enterprise and, thus, realize a small scale start up, present plans are based on the assumption that at least S$500 000 of external capital will be needed for the first two years.

These funds will primarily serve to finance Michelle’s position and a small team of lab assistants in charge of producing the protein complex for the clients. The product will be sold via a network of sales agents, and other functions, such as accounting and finance, will be outsourced to a professional accountant.

Answer all questions.
1. Should Michelle consider debt or equity to finance QuickBiotech? Explain your answer.

2. Would you consider any alternative sources or finance? Which one? Why?

3. Analyse other issues to be addressed before QuickBiotech is launched.

Please write all your answers in essay format. Do not answer in point-form unless the questions mention “List” or “State”. It is not necessary to precede each answer with an introduction and end with a summary. Proceed directly with the answer

PLEASE GUYS NEED ANSWER IN ESSAY,THANK YOU

College Graduation Rates. Data from the College Results Online website compared the 2011 graduation rate and median SAT score for 92 similar-sized public universities and colleges in the United States. The scatterplot below shows the relationship between these two variables along with the least squares fit. Round all calculated results to 4 decimal places. 1. The relationship between median SAT score and graduation rate is , , and . 2. The explanatory variable is and the response variable is . The summary statistics for graduation rate and median SAT score are listed below. The correlation between graduation rate and median SAT score is 0.673. Median SAT score: mean = 1038.1, standard deviation = 77.5 Graduation rate: mean = 49.4, standard deviation = 15 3. The equation of the regression line is y = + x 4. Complete the following sentence to interpret the slope of the regression line: An increase of in Median SAT score corresponds to a/an of in Graduation Rate. 5. The recorded median SAT score for Northern Michigan University is 1030. Use the regression equation to estimate the graduation rate for Northern Michigan University. 6. The recorded graduation rate for Northern Michigan University is 46.4. Complete the following sentence. The residual for Northern Michigan University is . This means the graduation rate at Northern Michigan University is A. the same as B. lower than C. higher than the rate predicted by the regression model. 7. Stanford University (an elite private university in California not included in this data set) has a median SAT score of 1455. Would it be appropriate to use this linear model to predict the graduation rate for Stanford? A. Yes, because 1455 is a reasonable median SAT score for an elite university. B. No, because 103.705% is too large to be a reasonable graduation rate, even for an elite university. C. No, because 1455 is beyond the range of the data used to build the regression model.

P9.29    Sales and labour budgets: university

Perth Business University (PBU) is preparing its budget for the upcoming academic year. This is a specialised private university that charges fees for all degree courses. Currently, 15 000 students are enrolled on campus. However, the university is forecasting a 5 per cent growth in student numbers in the coming year, despite an increase in fees to $3000per subject. The following additional information has been gathered from an examination of university records and conversations with university managers:

• Perth Business University is planning to award scholarships to 180 students, which will cover their fees.
• The average class has 80 students, and the typical student takes 4 subjects per semester. Perth Business University operates 2 semesters per year.
• The average academic staff salary is $100 000 per annum including oncosts.
• PBU’s academic staff are evaluated on the basis of teaching, research, administration and professional/community service. Each of the academic staff teaches the equivalent of three subjects during the academic year.

Required:

1. Prepare a revenue budget for the upcoming academic year.

2. Determine the number of staff needed to cover classes.

3. Assume there is a shortage of full-time academic staff. List at least five actions that PBU might take to accommodate the growing student numbers.

4. You have been requested by the university’s deputy vice chancellor (DVC) to construct budgets for other areas of operation (such as the library, grounds, cafeteria, and maintenance). The DVC noted: ‘The most important resource of the university is its academic staff. now that you know the number of staff needed, you can prepare the other budgets. Academic staff are indeed the key driver—without them we don’t operate’. Does the DVC really understand the linkages within the budgeting process? Explain.

A bond has a face value of $1,000, a coupon of 4% paid annually, a maturity of 33 years, and a yield to maturity of 7%. What rate of return will be earned by an investor who purchases the bond for $617.39 and holds it for 1 year if the bond’s yield to maturity at the end of the year is 8%?

The answer -15.82% is being marked as wrong please help!